Mark Gottlieb
@Altium Capital Management Lp
Latest period2024 - Q3ReportedManaged Assets$339.708MTotal holdings77
Assets growth rate-99.86%Assets growth rate (2-Q avg)-51.42%Continuous growth in asset value0 quarters
Portfolio positions
This chart displays the top 10 holdings in Altium Capital Management Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 77 positions.
Assets under management
The assets under management (AUM) of Altium Capital Management Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 339.708M in assets, with a quarterly growth rate of -99.86% and a 2-quarter average growth rate of -51.42%. The portfolio is managed by Mark Gottlieb, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
MISTMilestone Pharmaceuticals In
| 0.2% | $668,800 440,000 shares@ $1.52 avg price | Decreased -56.53% |
KPTIKaryopharm Therapeutics Inc
| 0.19% | $614,200 740,000 shares@ $0.83 avg price | |
UNCYUnicycive Therapeutics Inc
| 0.18% | $600,837 1.473M shares@ $0.41 avg price | New Position |
FATBWFat Brands Inc
| 0.15% | $499,000 200,000 shares@ $2.5 avg price | |
APLTApplied Therapeutics Inc
| 0.15% | $476,850↓ Put 56,100 shares@ $8.5 avg price | New Position |
CLRBCellectar Biosciences Inc
| 0.14% | $460,100 215,000 shares@ $2.14 avg price | New Position |
BTTRBetter Choice Co Inc
| 0.09% | $278,215 133,117 shares@ $2.1 avg price | New Position |
XPONExpion360 Inc
| 0.04% | $106,372 2.057M shares@ $0.06 avg price | New Position |
NXGLWNexgel Inc
| 0.03% | $91,474 225,000 shares@ $0.41 avg price | |
SCPXScorpius Holdings Inc
| 0.02% | $63,570 88,291 shares@ $0.73 avg price | New Position |